• About Us
  • Strategy
  • Our Team
  • Portfolio
  • News
  • Contact
  • About Us

    Accelmed Partners is a lower middle-market private equity firm focused on acquiring and investing in mature, U.S. based, commercial-stage HealthTech companies. For more than a decade, we have leveraged our deep HealthTech industry experience, operational and financial expertise, and strong relationships to help management teams at companies across the medical device, tools, diagnostics, digital health and tech-enabled services sectors position their businesses for future growth and success. Our ideal partners share our values of integrity, transparency and tenacity, directed toward leveraging technology to improve patient outcomes, reduce costs and increase efficiency throughout the healthcare system. We currently manage over $630 million of equity capital and are actively investing out of our second private equity fund, Accelmed Partners II.

    Header PatternHeader PatternHeader Pattern

    Our History

    A Track Record of Success

    2009

    Accelmed is founded by Uri Geiger with backing from Israeli healthcare entrepreneur Mori Arkin.

    timeline bullet

    2011

    Accelmed Ventures is launched with $100m and goes on to invest in 15 companies from pre-seed through Series A.

    timeline bullet

    2016

    Accelmed launches Accelmed Partners I, LP, a private equity fund focused on making control and growth investments in commercial-stage HealthTech companies. Accelmed Partners I, LP closes at $130m and later receives an additional $80m in co-investments from limited partners.

    timeline bullet

    2020

    Accelmed announces first closing of its second private equity fund, Accelmed Partners II, LP, and opens its first office in Miami, FL.

    timeline bullet

    2021

    Accelmed successfully closes its second private equity fund, Accelmed Partners II, LP, at the hard cap of $400 million, exceeding its original $300 million target.

    timeline bullet

    Strategy

    Leaders in Healthcare Technology Investing

    Learn More